One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Introduction to Microarray Chip Analysis TechnologyApril 10, 2024Microarray chip analysis technology, as an important innovation in the field of modern biotechnology, plays an increasingly important role in the fields of genomics, proteomics, and disease diagnosis ...view
What Is The Normal Metabolic Testing?March 11, 2024In the rapidly evolving landscape of healthcare diagnostics, metabolic testing has emerged as a cornerstone for understanding individual health profiles and tailoring interventions accordingly. Capita...view
Diagnosis of Colorectal Cancer from Three AspectsApril 4, 2023Coloretal cancer is a common digestive tract tumor with high malignancy. If it is not detected timely, the patient's condition is usually already in the middle or late stages. There are three main...view
Technical Principles and Functions of Gene SequencingDecember 1, 2022Gene sequencing is a new type of genetic testing technology, which can analyze and determine the full sequence of genes from blood or saliva, predict the possibility of suffering from various diseases...view